MedPath

Mekos Laboratories AS

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:1
Completed:2

Trial Phases

2 Phases

Phase 2:2
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Phase 4
1 (33.3%)

Quaternium-15, Use Test

Phase 4
Conditions
Allergic Contact Dermatitis Towards Quaternium-15
First Posted Date
2006-04-06
Last Posted Date
2006-04-06
Lead Sponsor
Mekos Laboratories AS
Target Recruit Count
10
Registration Number
NCT00311454
Locations
🇩🇰

Amtssygehuset i Gentofte, Gentofte, Denmark

Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate

Phase 2
Completed
Conditions
Allergic Contact Dermatitis
First Posted Date
2005-08-23
Last Posted Date
2006-02-27
Lead Sponsor
Mekos Laboratories AS
Target Recruit Count
60
Registration Number
NCT00133341
Locations
🇩🇰

Odense University Hospital, Odense, Odense C, Denmark

Clinical Evaluation of Bacitracin

Phase 2
Completed
Conditions
Allergic Contact Dermatitis
First Posted Date
2005-08-22
Last Posted Date
2005-10-19
Lead Sponsor
Mekos Laboratories AS
Target Recruit Count
20
Registration Number
NCT00132600
Locations
🇺🇸

Dermatological Clinic (Joseph Fowler MD), Louisville, Kentucky, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.